Apheresis Market Size by Product (Device (Centrifugation, Membrane Separation) Disposable), Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), Region - Global Forecast to 2029
The global apheresis market in terms of revenue was estimated to be worth USD 2.6 billion in 2024 and is poised to reach USD 3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
Growth of the market is mainly driven by upsurge in demand for source plasma from biopharmaceutical companies, and increase in demand for blood components and growing concerns regarding blood safety.
Attractive opportunities in the Apheresis Market
To know about the assumptions considered for the study, Request for Free Sample Report
Apheresis Market Dynamics
DRIVER: Rise in number of chronic diseases across the globe
The upsurging prevalence of chronic diseases worldwide serves as a key driving factor in the expansion of the market. Chronic conditions are characterized by their prolonged duration and gradual progression, encompass a wide range of diseases such as cardiovascular diseases, diabetes, cancer, and autoimmune disorders. For instance, according to the Evidence-Based Practice of Palliative Medicine Second Edition released in 2023, nearly half of individuals aged 65 to 69 suffer from two or more chronic ailments, a figure that rises to 75% among those over 85. Thus, as the populations age and lifestyle patterns evolve, the incidence of chronic diseases continues to climb, generating heightened demand for advanced therapeutic solutions like apheresis. Apheresis procedures offer a precise method for managing diseases by removing harmful substances from the bloodstream. Moreover, with ongoing technological innovations and increasing awareness among healthcare professionals and patients, apheresis procedures are becoming more accessible and are being progressively incorporated into treatment methods for effectively managing chronic diseases. thus, increasing the growth of the market throughout the forecast period.
RESTRAINT: High cost of apheresis devices decreasing the adoption
The market faces a significant restraining factor in the form of the high cost associated with apheresis devices, which in turn impedes their widespread adoption. The substantial initial investment required to acquire apheresis devices presents a barrier to their adoption, particularly for smaller healthcare facilities or those operating in resource-constrained settings. Moreoer, the high cost of apheresis devices encompasses not only the purchase price but also maintenance, consumables, and specialized training for healthcare professionals. This financial burden may dissuade healthcare providers from investing in apheresis technology, limiting patient access to these potentially life-saving procedures. Additionally, concerns regarding the cost-effectiveness of apheresis treatments compared to alternative therapies or traditional blood banking methods may further impact adoption rates.
OPPORTUNITY: Apheresis for leukemia and pediatric patients
The growing adoption of mainly therapeutic apheresis, particularly in the treatment of diseases such as leukemia, presents a significant opportunity within the market, particularly for paediatric patients. For instance, in the US for 2024, the American Cancer Society projects approximately 62,770 new instances of leukemia across all subtypes, with an estimated 23,670 fatalities attributed to the disease. The apheresis process involves removing specific components from a patient's blood and returning the rest to the body. In the case of leukemia, therapeutic apheresis plays a crucial role in managing the disease by removing excess white blood cells, which are often malignant, from the patient's bloodstream. This process helps alleviate symptoms and can even contribute to remission in some cases, making it a vital component of leukemia treatment protocols. Additionally, apheresis allows for precise control over the removal of harmful cells, minimizing the risk of complications and reducing the need for aggressive interventions. This makes it a preferred option for many parents and healthcare providers seeking the best possible outcomes for paediatric leukemia patients, thus showing the lucrative growth of the market.
CHALLENGE: Safety of blood transfusion in developing countries
The safety of blood transfusions in developing countries poses a significant challenge for the market, primarily due to concerns surrounding the transmission of infectious agents such as HIV, HBV, and others. In many developing regions, blood transfusion services face various obstacles, including inadequate infrastructure, limited resources, and insufficient regulatory oversight. As a result, there is a heightened risk of transfusion-transmitted infections, which can have severe consequences for both patients and healthcare systems. Moreover, increasing prevalence of infectious diseases underscore the importance of addressing transfusion safety on a global scale. The emergence of new pathogens and the potential for outbreaks pose ongoing challenges for blood transfusion services, particularly in regions with limited capacity for screening and testing. Thus, the safety concerns of blood transfusion in developing countries is posing a challenge to the market.
Apheresis Market Ecosystem
Prominent companies in this market are market Terumo BCT, Inc. (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Baxter International Inc. (US), Asahi Kasei Medical Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Cerus Corporation (US), Kaneka Corporation (Japan), SB-Kawasumi Laboratories, Inc (Japan), ), LMB Technologie GmbH (Germany), Bioelettronica S.r.l. (Italy), Infomed SA (Switzerland), Cytosorbents Corporation (US), Nikkiso Co., Ltd (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co., Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Becton, Dickinson and Company (US), Medicap clinic GmbH (Germany), Haier Biomedical (China), Beijing ZKSK Technology Co., Ltd. (China), Guangzhou Daji Medical Science and Technology Co. Ltd (China), PuriBlood Medical (Taiwan).
The Device segment is expected to grow at the highest CAGR from 2024 to 2029 in apheresis industry
Based on product, the apheresis market is segmented into apheresis devices and disposables. Among these the apheresis device segment is expected to show the growth of at the fastest rate. The apheresis device segment is again divided into two Sub-segments, centrifugation apheresis device and membrane separators. The centrifugation apheresis device holds the largest share in the apheresis device segment in 2023, attributing to several key advantages it offers over membrane separation technology. As centrifugation apheresis devices are known for their high efficiency in separating blood components, making them a preferred choice for therapeutic procedures hence, these are highly sought after by healthcare providers seeking comprehensive treatment options for various conditions, such as leukaemia, autoimmune disorders, and neurological diseases. This is leading to increasing adoption of centrifugation apheresis devices in hospitals, driving the growth of this segment within the market.
The plasmapheresis accounted for the largest share of the apheresis industry.
By application, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, photopheresis, and other applications including, lipidpheresis, lymphapheresis, immunoadsorption and stem cell collection. Among these, plasmapheresis segment accounted for the largest market share, attributing to its widespread adoption in the treatment of various neurological, immunological, and renal diseases. Plasmapheresis, also known as therapeutic plasma exchange, is a crucial therapeutic intervention utilized in the management of conditions such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), myasthenia gravis, thrombotic thrombocytopenic purpura (TTP), renal diseases, and rheumatic diseases. Its efficacy in removing harmful antibodies, immune complexes, and other pathogenic factors from the plasma makes it an indispensable treatment option for patients suffering from these debilitating illnesses. Thus, as the prevalence of neurological and autoimmune diseases continues to rise globally, the demand for plasmapheresis as a therapeutic intervention is expected to grow substantially, driving the expansion of this market segment.
Blood Collection Centers and blood component providers accounted for the largest share of the apheresis industry.
Based on end-users, the apheresis market is segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users including, emergency medical device providers, acute care centers, and medical & academic institutes. Among these, blood collection centers and blood component providers segment accounted for the largest share of the market, attributing to the rising demand for apheresis devices and related disposables within this segment. Blood collection centers and blood component providers play a pivotal role in the healthcare ecosystem by collecting, processing, and distributing blood products to meet the needs of patients undergoing various medical treatments, surgeries, and transfusions. As the demand for blood components such as plasma, platelets, and red blood cells continues to grow, these facilities require advanced apheresis technologies to efficiently collect and separate these components from whole blood donations. Thus, this rise in demand from blood collection centers and blood component providers is leading to increase the growth of the market over the forecast period.
North America accounted for the largest share of the apheresis industry in 2023.
To know about the assumptions considered for the study, download the pdf brochure
Based on the region, the apheresis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America accounted for the largest share of the market. This is due to increase in prevalence of chronic diseases, such as cardiovascular diseases, cancer, and autoimmune disorders. This is leading to increased need for therapeutic interventions, including apheresis procedures, to manage these diseases effectively. As a result, healthcare facilities across North America increasingly rely on apheresis technologies to provide crucial treatment options for patients with chronic illnesses, thereby driving the market's growth. Moreover, rising instances of surgical procedures in North America further bolster the demand for apheresis products and services. As surgical interventions often require blood transfusions, necessitating the availability of adequate blood components like platelets and plasma. Apheresis plays a pivotal role in obtaining these specific blood components efficiently and safely, ensuring a steady supply for surgical procedures, thus contributing significantly to the dominance of North America in the market.
Prominent players in apheresis market include Terumo BCT, Inc. (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Baxter International Inc. (US), Asahi Kasei Medical Co., Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Becton, Dickinson and Company (US), LMB Technologie GmbH (Germany), Beijing ZKSK Technology Co., Ltd. (China), Guangzhou Daji Medical Science and Technology Co. Ltd (China), Bioelettronica S.r.l. (Italy), Infomed SA (Switzerland), Cytosorbents Corporation (US), Medicap clinic GmbH (Germany), Haier Biomedical (China), B. Braun Melsungen AG (Germany), Cerus Corporation (US), Kaneka Corporation (Japan), SB-Kawasumi Laboratories, Inc (Japan), Nikkiso Co., Ltd (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co., Ltd. (Japan), PuriBlood Medical (Taiwan).
Scope of the Apheresis Industry
|
Report Metric |
Details |
|
Market Revenue in 2024 |
$2.6 billion |
|
Projected Revenue by 2029 |
$3.9 billion |
|
Revenue Rate |
Poised to Grow at a CAGR of 8.8% |
|
Market Driver |
Rise in number of chronic diseases across the globe |
|
Market Opportunity |
Apheresis for leukemia and pediatric patients |
The study categorizes the Apheresis Market to forecast revenue and analyze trends in each of the following submarkets:
By Product
- Apheresis disposables
-
Apheresis devices
- Centrifugal apheresis devices
- Membrane separators
By Procedure
- Automated blood collection
-
Therapeutic apheresis
-
Therapeutic apheresis disposables
- Neurological disorders
- Blood disorders
- Renal disorders
- Autoimmune disorders
- Metabolic disorders
- Cardiovascular disorders
- Other disorders
- Therapeutic apheresis devices
-
Therapeutic apheresis disposables
By Technology
-
Centrifugation
- Continuous flow centrifugation
- Intermittent flow centrifugation
- Membrane separation
By Application
- Plasmapheresis
- Plateletpheresis
- Erythrocytapheresis
- Leukapheresis
- Photopheresis
- Other applications
By End User
- Blood collection centers and blood component providers
- Hospitals and transfusion centers
- Other end users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- Italy
- Spain
- France
- RoE
-
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- RoAPAC
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
-
Middle East and Africa
- GCC Countries
- Rest of Middle East and Africa
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global apheresis market?
The global apheresis market boasts a total revenue value of $3.9 billion by 2029.
What is the estimated growth rate (CAGR) of the global apheresis market?
The global apheresis market has an estimated compound annual growth rate (CAGR) of 8.8% and a revenue size in the region of $2.6 billion in 2024. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
The study involved four major activities to estimate the current size of the apheresis market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of apheresis Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after obtaining information regarding the apheresis market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the apheresis market.; and key opinion leaders.
Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.
The following is a breakdown of the primary respondents:
Breakdown of Primary Participants:
Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
Note 2: Other primaries include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue.
As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=<USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the apheresis market includes the following details.
The market sizing of the market was undertaken from the global side.
Country-level Analysis: The size of the apheresis market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall apheresis market was obtained from secondary data and validated by primary participants to arrive at the total apheresis market. Primary participants further validated the numbers.
Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall apheresis market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Apheresis Market Size: Top-Down Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Global Apheresis Market Size: Bottom-Up Approach
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the apheresis industry.
Market Definition:
The apheresis market encompasses the global business sphere surrounding the development, production, distribution, and use of apheresis equipment and related consumables. This specialized technology enables the separation and collection of specific blood components, such as plasma, platelets, or white blood cells, from a whole blood donation. These collected components are then used in various therapeutic applications, including treating blood disorders, autoimmune diseases, and neurological conditions.
Key Stakeholders
- Apheresis devices manufacturers and distributors
- Hospitals and transfusion centers
- Therapeutic apheresis service providers
- Blood banks and blood collection centers
- Plasma fractionation companies
- Healthcare providers
- Academic research institutes
- Pharmaceutical companies
- Contract research organizations (CROs)
- Market research & consulting firms
Report Objectives
- To define, describe, segment, and forecast the global apheresis market by product, technology, procedure, application, end user, and region.
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall apheresis market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
- To forecast the size of the apheresis market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players in the global apheresis market and comprehensively analyze their core competencies2 and market shares.
- To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
- To benchmark players within the apheresis market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
- Geographic Analysis: Further breakdown of the Latin American apheresis into specific countries and, the Middle East, and Africa apheresis into specific countries and further breakdown of the European apheresis into specific countries
Generating Response ...
Growth opportunities and latent adjacency in Apheresis Market